Savani Group Owners and Associate Convicted of Racketeering Conspiracy

PHILADELPHIA - United States Attorney David Metcalf announced that three individuals were convicted today at trial in connection with a racketeering conspiracy encompassing multiple fraud schemes.

The defendants, charged in a 42-count indictment in January 2023, have been convicted as follows:

Dr. Bhaskar Savani, age 60, of Ambler, Pennsylvania, was convicted of one count of conspiring to violate the RICO law; one count of conspiring to commit visa fraud; one count of visa fraud; one count of conspiring to obstruct justice; one count of conspiring to commit healthcare fraud; eleven counts of healthcare fraud; one count of conspiring to engage in money laundering; twelve counts of money laundering; one count of conspiring to defraud the Internal Revenue Service; one count of wire fraud as to a false tax return; and one count of conspiring to violate the Food, Drug, and Cosmetic Act.

Arun Savani, age 58, of Blue Bell, Pennsylvania, was convicted of one count of conspiring to violate the RICO law; one count of conspiring to commit visa fraud; one count of visa fraud; one count of conspiring to obstruct justice; one count of conspiring to commit healthcare fraud; eleven counts of healthcare fraud; one count of conspiring to engage in money laundering; twelve counts of money laundering; one count of conspiring to defraud the Internal Revenue Service; and one count of wire fraud as to a false tax return.

Aleksandra Radomiak, a/k/a "Ola", age 48, of Lansdale, Pennsylvania, was convicted of one count of conspiring to violate the RICO law; one count of conspiring to commit healthcare fraud; and one count of healthcare fraud.

As proven at trial, the brothers Bhaskar Savani and Arun Savani built a complex criminal enterprise (the "Savani Group") that amassed millions of dollars through multiple fraud schemes. Defendant Bhaskar Savani was a dentist by training. Defendant Arun Savani generally controlled the finances of the Savani Group. Through their criminal enterprise, Bhaskar and Arun Savani orchestrated long-running schemes to enrich themselves, including through:

• A visa fraud scheme to file false H-1B visa applications and petitions with the U.S. Department of Labor and U. S. Citizenship and Immigration Services to exploit a workforce comprised of foreign nationals, mostly from India, who were dependent on the Savani Group and forced to kickback wages and fees to the Savani Group.
• A health care fraud scheme to fraudulently obtain Medicaid contracts and fraudulently bill Medicaid using nominee business owners after Savani Group dental practices were terminated from Medicaid insurance contracts. The Savani Group defrauded Medicaid of more than $30 million through the scheme.
• A health care fraud scheme to submit false bills to Medicaid using another dentist's National Provider Identifier (NPI) on dates when the other dentist was physically outside of the United States and for dental services performed by uncredentialed dentists.
• A money laundering scheme to transfer and conceal health care fraud proceeds from the nominee-owned dental practices through a complex web of Savani group corporate entities' bank accounts that ultimately benefited the Savani brothers and their associated corporate entities.
• A tax and wire fraud scheme involving false business expenses and the failure to report some taxable payroll to fraudulently decrease the amount of personal and payroll taxes due and owing. Through the scheme the Savani brothers and their companies failed to pay taxes on approximately $1.6 million of unreported personal income and $1.1 million of their employees' unreported income. They failed to pay personal and payroll taxes and fraudulently expensed through their businesses, among other personal expenses, college tuition payments, personal property taxes, and pool and lawn maintenance costs for their personal homes.
• A mail fraud scheme and Federal Food, Drug, and Cosmetic Act (FDCA) conspiracy to place prototype dental implants, labeled "Not For Human Use," not cleared by the U.S. Food and Drug Administration, in human patients without their knowledge or consent.

The defendants will be sentenced in July 2026. Bhaskar and Arun Savani, respectively, face a statutory maximum sentence of 420 years' imprisonment and 415 years' imprisonment, along with fines. Defendant Aleksandra Radomiak also faces a substantial sentence, with up to 40 years' imprisonment and fines.

"This sprawling investigation and prosecution meant untangling a complex web of fraudulent billing practices and sham medical entities," said U.S. Attorney Metcalf. "Our office worked with numerous state and federal partner agencies to unravel and prove the multiple healthcare fraud schemes at the heart of this operation. It's gratifying to dismantle this crooked enterprise and hold those responsible to account. Fraud and abuse cost U.S. taxpayers billions of dollars a year and rob the healthcare system of vital resources."

"This significant prosecution exemplifies the commitment of the Department of Justice and its law enforcement partners to protect taxpayer-funded programs from fraudsters and corrupt healthcare professionals who seek their own personal enrichment by bilking government programs and then laundering their ill gotten gains," said Assistant Attorney General A. Tysen Duva. "The Criminal Division, and all of our partners including the Eastern District of Pennsylvania, will continue using every law enforcement tool available to identify, disrupt and dismantle organized fraud and those who corruptly manipulate the worker visa and Medicaid programs. Fraudsters and money launderers like Bhaskar and Arun Savani and their associates who do so will pay a heavy price."

"This conviction demonstrates the critical importance of partnerships across law enforcement agencies when confronting complex financial and organized criminal activity," said Wayne A. Jacobs, special agent in charge of FBI Philadelphia. "By leveraging our collective expertise and resources, we were able to expose and dismantle a racketeering enterprise built on deception and fraud. The FBI, working closely alongside our law enforcement and prosecutorial partners, will continue to pursue those who exploit others for personal profit and bring them to justice."

"Today's verdict sends a clear message: those who corrupt the Medicaid program for personal gain-no matter how elaborate their schemes-will be held fully accountable," said Maureen Dixon, Special Agent in Charge of the Department of Health and Human Services Office of Inspector General (HHS-OIG). "The Savani Enterprise exploited vulnerable patients, manipulated government programs, and siphoned taxpayer dollars for their own benefit. HHS-OIG, alongside our federal and state law enforcement partners, remains unwavering in our commitment to protect the integrity of Medicaid and to defend the public's trust in our healthcare system."

"The defendants orchestrated a years-long scheme to defraud Medicaid, evade taxes, and launder millions of dollars through a complex network of companies and accounts," stated Special Agent in Charge Jenifer L. Piovesan, IRS Criminal Investigation, Newark Field Office. "These crimes do not just enrich wrongdoers, they drain vital public resources and erode trust in government programs. These convictions make clear that those who defraud the government will be held accountable. IRS-CI will continue to work alongside our law enforcement partners to dismantle financial fraud schemes and protect the public."

"Today's convictions send a clear message that those who build criminal enterprises on the backs of vulnerable patients, exploited workers, and U.S. taxpayers will be held to account," said Special Agent in Charge of HSI Philadelphia, Eric McLoughlin, "For years, the Savani Group manipulated our immigration system, corrupted healthcare programs, and laundered their illicit proceeds through a maze of shell companies and accounts. This investigation and resulting prosecution reflect the strength of our partnerships with federal and state agencies and our shared commitment to dismantling complex fraud schemes wherever they take root."

"Visa fraud undermines our legal immigration system and often victimizes those seeking legitimate opportunities in the United States," said Anthony Tortora, Resident Agent in Charge at the DSS Philadelphia Resident Office. "The Diplomatic Security Service is committed to investigating these schemes and protecting the integrity of the visa process. This conviction sends a clear message that such fraud will not be tolerated."

"The FDA's approval process exists to protect patients from untested medical devices," said Fernando McMillan, Acting Special Agent in Charge, FDA Office of Criminal Investigations, Metro Washington Field Office. "These defendants deliberately circumvented that safeguard by implanting unapproved dental devices into unsuspecting patients. The FDA will not tolerate such disregard for public safety and federal law."

"Today's verdict holds the defendants accountable for their criminal conduct. The U.S. Department of Labor, Office of Inspector General is unwavering in its commitment to protect the integrity of the Foreign Labor Certification programs. When bad actors exploit vulnerable workers or attempt to game the system, we investigate, we expose, and we hold them accountable," said Anthony P. D'Esposito, Inspector General, Department of Labor, Office of Inspector General. "We will continue working with our local, state, and federal law enforcement partners to ensure these programs serve legitimate labor needs - not criminal enterprises. Fraud will not be tolerated. Accountability is not optional."

This case was investigated by the FBI, U.S. Department of Health and Human Services Office of Inspector General, Internal Revenue Service - Criminal Investigations, Homeland Security Investigations, U.S. Department of State's Diplomatic Security Service, Food and Drug Administration Office of Criminal Investigations, and the U.S. Department of Labor Office of Inspector General.

The case is being prosecuted by Assistant United States Attorneys Anthony D. Scicchitano, Paul Shapiro, and J. Andrew Jenemann, and Department of Justice Money Laundering, Narcotics, and Forfeiture Section Attorneys Kenneth P. Kaplan and Chelsea R. Rooney.